1. Liu, Gongbao, Liu, Baihui, Zheng, Shan, Dong, Kuiran, Dong, Rui. 2018. Aberrant RASSF5 gene transcribed region hypermethylation in pediatric hepatoblastomas. In International journal of clinical and experimental pathology, 11, 3612-3617. doi:. https://pubmed.ncbi.nlm.nih.gov/31949741/
2. Li, Shuofeng, Teng, Jingwei, Li, Haiqing, Chen, Feifei, Zheng, Junnian. . The Emerging Roles of RASSF5 in Human Malignancy. In Anti-cancer agents in medicinal chemistry, 18, 314-322. doi:10.2174/1871520617666170327120747. https://pubmed.ncbi.nlm.nih.gov/28356010/
3. Hossain, Md Shahadat, Roy, Arpita Singha, Islam, Md Sajedul. 2020. In silico analysis predicting effects of deleterious SNPs of human RASSF5 gene on its structure and functions. In Scientific reports, 10, 14542. doi:10.1038/s41598-020-71457-1. https://pubmed.ncbi.nlm.nih.gov/32884013/
4. Singh, Anamika, Erijman, Ariel, Noronha, Ashish, Yarden, Yosef, Shifman, Julia M. 2021. Engineered variants of the Ras effector protein RASSF5 (NORE1A) promote anticancer activities in lung adenocarcinoma. In The Journal of biological chemistry, 297, 101353. doi:10.1016/j.jbc.2021.101353. https://pubmed.ncbi.nlm.nih.gov/34717958/
5. Li, T K, Yin, K, Chen, Z, Bao, Y, Zhang, S X. 2017. MiR-214 regulates oral cancer KB cell apoptosis through targeting RASSF5. In Genetics and molecular research : GMR, 16, . doi:10.4238/gmr16019327. https://pubmed.ncbi.nlm.nih.gov/28290615/
6. Zhou, Julie Xia, Li, Linda Xiaoyan, Zhang, Hongbing, Calvet, James P, Li, Xiaogang. 2024. DNA methyltransferase 1 (DNMT1) promotes cyst growth and epigenetic age acceleration in autosomal dominant polycystic kidney disease. In Kidney international, 106, 258-272. doi:10.1016/j.kint.2024.04.017. https://pubmed.ncbi.nlm.nih.gov/38782200/
7. Zeng, Qi, Xiao, Yan, Zeng, Xueliang, Xiao, Hai. 2024. Implications of the SNHG10/miR-665/RASSF5/NF-κB pathway in dihydromyricetin-mediated ischemic stroke protection. In PeerJ, 12, e18754. doi:10.7717/peerj.18754. https://pubmed.ncbi.nlm.nih.gov/39726744/
智鼠故事 
